Global Mofy Metaverse Explores Partnership to Integrate Metaverse and AI Technology with Traditional Chinese and Western Therapeutic Practices

BEIJING, March 25, 2024 (GLOBE NEWSWIRE) -- Global Mofy Metaverse Limited (the "Company" or "Global Mofy Metaverse") (Nasdaq: GMM), a technology solutions provider engaged in virtual content production and the development of digital assets for use in the broader digital entertainment industry, today revealed that three-way strategic cooperation discussions were initiated with a senior professor from a renowned medical university in Beijing and his director team of its affiliated hospital, as well as the Metaverse Committee of the Beijing Big Data Association. The goal is to combine Metaverse and AI technologies with traditional Chinese and Western healing methods. This partnership aims to explore the vast potential for researchers, healthcare practitioners, and patients to harness the benefits of integrating these technologies into preventive healthcare and various treatments.

During the initial meeting, the team outlined a strategic approach focused on developing a system for training and education using virtual reality. This includes creating virtual interactive platforms for hands-on training, leveraging data analytics for enhanced learning experiences, and conceptualizing a virtual professor role to facilitate online training. These initiatives are aimed at transforming educational methodologies in healthcare, aligning with the futuristic vision of the partnership.

Mr. Haogang Yang, CEO of Global Mofy Metaverse, stated, “We are thrilled to engage in discussions with such a distinguished and respected expert in the medical field. Recognizing this as a high-priority adjacent market for us, we see an opportunity to utilize our investments and proven track record in developing commercially successful Metaverse and AI technologies and platform solutions. Our belief is that AI will revolutionize nearly every facet of the extensive global healthcare sector, from research and data analysis to predictive modeling, diagnostic tools, enhancing accuracy, and reducing costs. Partnering with an equally robust and committed collaborator will not only help us adhere to our product roadmap and R&D budget but also extend our competitive edge.”